LinkDoc Got Strategic Investment from AliHealth

LinkDoc Technology, an enterprise from TEDA, won strategic investment from AliHealth. The two sides will jointly build a whole disease cycle service platform for tumor patients in China, explore actively online innovative service model for cancer specialty drug, and build online plus offline service system for cancer specialty care.

AliHealth has a stronger presence in “Internet plus Pharmaceuticals”, boosting the development of scientific research, diagnosis and treatment of critical illnesses, and biological vaccines with the help of the Internet and technological innovation. LinkDoc Technology is committed to the R&D of tumor big data and AI, providing the overall solution of big data and AI for the pharmaceuticals and medicine. The cooperation lays a good foundation for LinkDoc Technology to bring more high-quality industrial resources into TEDA. In the future, backed by the two sides’ extensive expertise in critical illness, both sides will link to Ali Health Platform, LinkDoc Internet Hospital and Tumor Patient Service Center to provide users with more accurate, convenient and comprehensive critical illness services.